Further indications of the importance of the subcellular localization of PKCδ to its function was recently demonstrated by a study reporting its role in EGFR TK inhibitor resistance when localized in the nucleus in non–small cell lung cancer (Lee et al., 2018). Here, PRKCD is linked to lung cancer.